Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC

Pillai S. , Gopalan V. , Smith R.A. and Lam A.K. , Diffuse sclerosing variant of papillary thyroid carcinoma - an update of its clinicopathological features and molecular biology, Crit Rev Oncol Hematol 94 (2015), 64-73.

Goldfarb M. and Casillas J. , Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients, J Cancer Surviv 8 (2014), 394-401.

Donatini G. , Castagnet M. , Desurmont T. , Rudolph N. , Othman D. and Kraimps J.L. , Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated? World J Surg 40 (2016), 510-515.

Lee Y.S. , Lim H. , Chang H.S. and Park C.S. , Papillary thyroid microcarcinomas are different from latent papillary thyroid carcinomas at autopsy, J Korean Med Sci 29 (2014), 676-679.

Grant C.S. , Papillary thyroid cancer: strategies for optimal individualized surgical management, Clin Ther 36 (2014), 1117-1126.

Zhu W. , Zhong M. and Ai Z. , Systematic evaluation of prophylactic neck dissection for the treatment of papillary thyroid carcinoma, Jpn J Clin Oncol 43 (2013), 883-888.

Mourão G.F. , Rosario P.W. and Calsolari M.R. , Low postoperative nonstimulated thyro-globulin as a criterion to spare radioiodine ablation, Endocr Relat Cancer 23 (2016), 47-52.

Rosario P.W. , Furtado Mde S. , Mourão G.F. and Calsolari M.R. , Patients with papillary thyroid carcinoma at intermediate risk of recurrence according to american thyroid association criteria can be reclassified as low risk when the postoperative thyroglobulin is low, Thyroid 25 (2015), 1243-1248.

Tang W. , Huang C. , Tang C. , Xu J. and Wang H. , Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: a meta-analysis, Onco Targets Ther 9 (2016), 455-460.

Liu Z. , Yu P. , Xiong Y. , Zeng W. , Li X. , Maiaiti Y. , Wang S. , Song H. , Shi L. , Liu C. , Cheng B. , Zhang B. , Ming J. , Dong F. , Ge H. , Nie X. and Huang T. , Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma, Int J Clin Exp Med 8 (2015), 4369-4374.

Mansoori B. , Mohammadi A. , Shirjang S. and Baradaran B. , Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy, Cell Mol Biol (Noisy-le-grand) 61 (2015), 1-10.

Juanchich A. , Bardou P. , Rué O. , Gabillard J.C. , Gaspin C. , Bobe J. and Guiguen Y. , Characterization of an extensive rainbow trout miRNA transcriptome by next generation sequencing, BMC Genomics 17 (2016), 164.

Mangolini A. , Ferracin M. , Zanzi M.V. , Saccenti E. , Ebnaof S.O. , Poma V.V. , Sanz J.M. , Passaro A. , Pedriali M. , Frassoldati A. , Querzoli P. , Sabbioni S. , Carcoforo P. , Hollingsworth A. and Negrini M. , Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR, Biomark Res 3 (2015), 12.

Liu H. , Li W. , Chen C. , Pei Y. and Long X. , MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma, Tumour Biol 36 (2015), 6313-6319.

Rajendiran S. , Parwani A.V. , Hare R.J. , Dasgupta S. , Roby R.K. and Vishwanatha J.K. , MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1, Mol Cancer 13 (2014), 250.

Song B. , Zhang C. , Li G. , Jin G. and Liu C. , MiR-940 inhibited pancreatic ductal adenocarcinoma growth by targeting MyD88, Cell Physiol Biochem 35 (2015), 1167-1177.

Wang Q. , Shi S. , He W. , Padilla M.T. , Zhang L. , Wang X. , Zhang B. and Lin Y. , Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition, Oncotarget 5 (2014), 1304-1314.

Hassan T. , Smith S.G. , Gaughan K. , Oglesby I.K. , O'Neill S. , McElvaney N.G. and Greene C.M. , Isolation and identification of cell-specific microRNAs targeting a messenger RNA using a biotinylated anti-sense oligonucleotide capture affinity technique, Nucleic Acids Res 41 (2013), e71.

Liu X. , Kwong A. , Sihoe A. and Chu K.M. , Plasma miR-940 may serve as a novel biomarker for gastric cancer, Tumour Biol 37 (2016), 3589-3597.

Ma J. , Sun F. , Li C. , Zhang Y. , Xiao W. , Li Z. , Pan Q. , Zeng H. , Xiao G. , Yao K. , Hong A. and An J. , Depletion of intermediate filament protein Nestin, a target of microRNA-940, suppresses tumorigenesis by inducing spontaneous DNA damage accumulation in human nasopharyngeal carcinoma, Cell Death Dis 14 (2014), e1377.

Calin G.A. , Dumitru C.D. , Shimizu M. , Bichi R. , Zupo S. , Noch E. , Aldler H. , Rattan S. , Keating M. , Rai K. , Rassenti L. , Kipps T. , Negrini M. , Bullrich F. and Croce C.M. , Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia, Proc Natl Acad Sci U S A 99 (2002), 15524-15529.

Cimmino A. , Calin G.A. , Fabbri M. , Iorio M.V. , Ferracin M. , Shimizu M. , Wojcik S.E. , Aqeilan R.I. , Zupo S. , Dono M. , Rassenti L. , Alder H. , Volinia S. , Liu C.G. , Kipps T.J. , Negrini M. and Croce C.M. , miR-15 and miR-16 induce apoptosis by targeting BCL2, Proc Natl Acad Sci U S A 102 (2005), 13944-13949.

Cai C.K. , Zhao G.Y. , Tian L.Y. , Liu L. , Yan K. , Ma Y.L. , Ji Z.W. , Li X.X. , Han K. , Gao J. , Qiu X.C. , Fan Q.Y. , Yang T.T. and Ma B.A. , miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma, Oncol Rep 28 (2012), 1764-1770.

Hart M. , Nolte E. , Wach S. , Szczyrba J. , Taubert H. , Rau T.T. , Hartmann A. , Grässer F.A. and Wullich B. , Comparative microRNA profiling of prostate carcinomas with increasing tumor stage by deep sequencing, Mol Cancer Res 12 (2014), 250-263.

Diniz M.G. , Gomes C.C. , de Castro W.H. , Guimarães A.L. , De Paula A.M. , Amm H. , Ren C. , MacDougall M. and Gomez R.S. , miR-15a/16-1 influences BCL2 expression in keratocystic odontogenic tumors, Cell Oncol (Dordr) 35 (2012), 285-291.

Luo Q. , Li X. , Li J. , Kong X. , Zhang J. , Chen L. , Huang Y. and Fang L. , MiR-15a is under-expressed and inhibits the cell cycle by targeting CCNE1 in breast cancer, Int J Oncol 43 (2013), 1212-1218.

Liu X. , He M. , Hou Y. , Liang B. , Zhao L. , Ma S. , Yu Y. and Liu X. , Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma, Oncol Rep 29 (2013), 1415-1420.

Wang F. , Jiang C. , Sun Q. , Yan F. , Wang L. , Fu Z. , Liu T. and Hu F. , miR-195 is a key regulator of Raf1 in thyroid cancer, Onco Targets Ther 8 (2015), 3021-3028.

Chen D. , Li W. , Liu S. , Su Y. , Han G. , Xu C. , Liu H. , Zheng T. , Zhou Y. and Mao C. , Interleukin-23 promotes the epithelial-mesenchymal transition of oesophageal carcinoma cells via the Wnt/β -catenin pathway, Sci Rep 5 (2015), 8604.

Klein A. , Schwartz H. , Sagi-Assif O. , Meshel T. , Izraely S. , Ben Menachem S. , Bengaiev R. , Ben-Shmuel A. , Nahmias C. , Couraud P.O. , Witz I.P. and Erez N. , Astrocytes facilitate melanoma brain metastasis via secretion of IL-23, J Pathol 236 (2015), 116-127.

Li J. , Lau G. , Chen L. , Yuan Y.F. , Huang J. , Luk J.M. , Xie D. and Guan X.Y. , Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression, PLoS One 7 (2012), e46264.

Suzuki H. , Ogawa H. , Miura K. , Haneda S. , Watanabe K. , Ohnuma S. , Sasaki H. , Sase T. , Kimura S. , Kajiwara T. , Komura T. , Toshima M. , Matsuda Y. , Shibata C. and Sasaki I. , IL-23 directly enhances the proliferative and invasive activities of colorectal carcinoma, Oncol Lett 4 (2012), 199-204.

Mei Z. , Chen S. , Chen C. , Xiao B. , Li F. , Wang Y. and Tao Z. , Interleukin-23 facilitates thyroid cancer cell migration and invasion by inhibiting SOCS4 expression viaMicroRNA-25, PLoS One 10 (2015), e0139456.

Harquail J. , Benzina S. and Robichaud G.A. , MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis, Cancer Epidemiol Biomarkers Prev 11 (2012), 269-280.

Wang H. , Tan G. , Dong L. , Cheng L. , Li K. , Wang Z. and Luo H. , Circulating miR-125B as a marker predicting chemoresistance in breast cancer, PLoS One 7 (2012), e34210.

Klein U. , Lia M. , Crespo M. , Siegel R. , Shen Q. , Mo T. , Ambesi-Impiombato A. , Califano A. , Migliazza A. , Bhagat G. and Dalla-Favera R. , The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia, Cancer Cell 17 (2010), 28-40.

Liu X. , Gu X. , Sun L. , Flowers A.B. , Rademaker A.W. , Zhou Y. and Kiyokawa H. , Down-regulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: Involvement of the RB-microRNA axis, BMC Cancer 14 (2014), 57.

Mangano A. , Mangano A. , Lianos G.D. , Cassinotti E. , Roukos D.H. , Dionigi G. and Boni L. , Circulating free DNA in plasma or serum as biomarkers of carcinogenesis in colon cancer, Future Oncol 11 (2015), 1455-1458.

Jia L. , Hao F. , Wang W. and Qu Y. , Circulating miR-145 is associated with plasma high-sensitivity C-reactive protein in acute ischemic stroke patients, Cell Biochem Funct 33 (2015), 314-319.

El-Akawi Z.J. , Abu-Awad A.M. , Sharara A.M. and Khader Y. , The importance of alpha-1 antitrypsin (alpha1-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients, Neuro Endocrinol Lett 31 (2010), 113-116.